Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Mounjaro often produces greater average weight loss due to its dual-receptor action
Ali also points out that more research is needed
This matters because lean soft tissue loss comprised 26% to 40% of weight loss in recent trials of GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists
Retatrutide itself is still being evaluated in controlled clinical trial settings, meaning its full safety profile even as a standalone compound has not yet been established
Mattenberger Y, James DI, Martinou JC
US$ 26.95
US$ 25.94
US$ 22.45
US$ 29.02
